FIP Development Goal 8 [w]

Globally, we will have:

Clearly identifiable elements of collaborative working and interprofessional education and training which should be a feature of all workforce development programmes and policies.

Mechanisms

• Evidence of policy formation to demonstrate how healthcare professionals can develop and engage in partnerships to achieve better health outcomes.

• Develop education and training strategies and programmes to ensure collaboration within the pharmaceutical workforce and training on medicines for other healthcare professionals.

• Ideally, this should be linked with formal professional development activities.

FIP Development Goal 8 [p]

Globally, we will have:

Clearly identifiable elements of inter- and intra-professional collaboration and multi-disciplinary healthcare, delivered through​ cohesive and interdependent teams working across interfaces and transitions of care

Mechanisms

• Develop structures and systems for multidisciplinary intra- and interprofessional teams of all relevant health cadres to work together in a coordinated manner across all levels of care. This should include pharmaceutical practice for optimal people-centred care delivery in primary, secondary and tertiary health settings.

• Work across interfaces and transitions of the health system (including digital interfaces) to ensure continuity of care between levels of care and care journeys through mechanisms such as appropriate communications and health data sharing, shared decision-making, shared accountability for patient outcomes, and services such as medicines reconciliation or collaborative management of long-term conditions.

• Support the development of policies where pharmacists and the support workforce are key actors in collaborative practice and integrated care.

• Work with stakeholders, agencies, and other health professional associations to enable legislative change and development.

• Ensure engagement of patients, formal and informal caregivers and community health workers in multidisciplinary health decision making through their empowerment, improved health literacy and orientation, participation and connectivity in the team as ambassadors for their own and their communities’ health.

• Recognise own professional autonomy and leadership, equal responsibility and accountability with other health professionals in terms of the scope of practice.

• Recognise collaborative practice as a quality indicator for care delivery and capacity improvement.

• Develop and implement intra- and interdisciplinary programmes for workforce willing to change from practice to sciences and vice versa or develop career paths in associated fields.

FIP Development Goal 8 [s]

Globally, we will have:

Transdisciplinary collaboration to advance education, research, development, manufacturing and regulations that collectively improve access to medical products.

Mechanisms

• Establish opportunities for pharmaceutical scientists and clinical practitioners to collaborate.

• Broaden pharmaceutical sciences education by integrating other disciplines that contribute to innovation, development and manufacturing, and regulations of medical products.

• Foster transdisciplinary collaboration by enabling trainees and early career researchers to work with mentors from different fields.